Shixia Wang

Overview

Best Publications

• The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

  S. W. Barnett;S. Lu;I. Srivastava;S. Cherpelis

  352
  Citations

• Effect of vaccine administration modality on immunogenicity and efficacy.

  Lu Zhang;Wei Wang;Shixia Wang

  269
  Citations

• Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers

  Shixia Wang;Jeffrey S. Kennedy;Kim West;David C. Montefiori

  224
  Citations

• Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants

  Robyn Marty-Roix;Gregory I. Vladimer;Kimberly Pouliot;Dan Weng

  215
  Citations

• The wide utility of rabbits as models of human diseases

  Pedro J. Esteves;Joana Abrantes;Hanna Mari Baldauf;Lbachir BenMohamed

  201
  Citations

• Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E

  Shixia Wang;Ranajit Pal;John R. Mascola;Te-Hui W. Chou

  174
  Citations

• Current progress of DNA vaccine studies in humans.

  Shan Lu;Shixia Wang;Jill M Grimes-Serrano

  172
  Citations

• EV71: An emerging infectious disease vaccine target in the Far East?

  Juan Xu;Yuan Qian;Shixia Wang;Shixia Wang;Jill M. Grimes Serrano

  171
  Citations

• Follicular regulatory T cells repress cytokine production by follicular helper T cells and optimize IgG responses in mice.

  Hao Wu;Yuxin Chen;Hong Liu;Lin Lin Xu

  170
  Citations

• Hemagglutinin (HA) Proteins from H1 and H3 Serotypes of Influenza A Viruses Require Different Antigen Designs for the Induction of Optimal Protective Antibody Responses as Studied by Codon-Optimized HA DNA Vaccines

  Shixia Wang;Jessica Taaffe;Christopher S. Parker;Alicia Solorzano

  169
  Citations

• Protection Against Rotavirus Infections By DNA Vaccination

  John E. Herrmann;Shing C. Chen;Ellen F. Fynan;Joseph C. Santoro

  149
  Citations

• Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1

  Shixia Wang;James Arthos;John M. Lawrence;Donald I. Van Ryk

  149
  Citations

• Improved Induction of Antibodies against Key Neutralizing Epitopes by Human Immunodeficiency Virus Type 1 gp120 DNA Prime-Protein Boost Vaccination Compared to gp120 Protein-Only Vaccination

  Michael Vaine;Shixia Wang;Emma T. Crooks;Pengfei Jiang

  139
  Citations

• Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype

  Ranajit Pal;Shixia Wang;V.S. Kalyanaraman;B.C. Nair

  138
  Citations

• Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.

  Shixia Wang;Diego J. Farfan-Arribas;Siyuan Shen;Te-hui W. Chou

  136
  Citations

• The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods

  Shixia Wang;Chunghua Zhang;Lu Zhang;Jun Li

  136
  Citations

• Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.

  Michael Vaine;Shixia Wang;Anthony Hackett;James Arthos

  136
  Citations

• Heterologous HA DNA vaccine prime - inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses

  Shixia Wang;Chris Parker;Jessica Taaffe;Alicia Solórzano

  130
  Citations

• Increased Immunogenicity of Human Immunodeficiency Virus gp120 Engineered To Express Galα1-3Galβ1-4GlcNAc-R Epitopes

  Ussama M. Abdel-Motal;Shixia Wang;Shan Lu;Kim Wigglesworth

  118
  Citations

• Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions.

  Shan Lu;Richard T. Wyatt;Joan F. L. Richmond;Farah Mustafa

  117
  Citations